Lipid Target Achievement Among Patients With Very High and High Cardiovascular Risk in a Lipid Clinic

被引：27

作者：

Barkas, Fotios ^{[1
]}

Liberopoulos, Evangelos N. ^{[1
]}

Kostapanos, Michael S. ^{[1
]}

Liamis, George ^{[1
]}

Tziallas, Dimitrios ^{[1
]}

Elisaf, Moses ^{[1
]}

机构：

[1] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece

来源：

ANGIOLOGY | 2015年 / 66卷 / 04期

关键词：

dyslipidemia; high risk; treatment target; cardiovascular disease; lipid clinic; low-density lipoprotein cholesterol; guidelines; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; CHRONIC KIDNEY-DISEASE; GOAL ATTAINMENT; GREEK ATORVASTATIN; EUROPEAN COUNTRIES; METABOLIC SYNDROME; EVALUATION GREACE; STATIN TREATMENT; UNITED-STATES;

D O I：

10.1177/0003319714535073

中图分类号：

R6 [外科学];

学科分类号：

100210 [外科学];

摘要：

This was a retrospective study that assessed achievement of lipid-lowering treatment targets in the setting of a University Hospital Lipid Clinic. Low-density lipoprotein cholesterol (LDL-C) goal attainment according to National Cholesterol Education Program-Adult Treatment Panel III (NCEP ATP III) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) guidelines was recorded in 1000 consecutive adult patients followed for 3 years (mean 8 years). The LDL-C targets according to the NCEP ATP III were attained by 66% and 86% of patients with very high (n = 477) and high (n = 408) cardiovascular risk, respectively. Fewer patients were within LDL-C goals according to the ESC/EAS guidelines: 25% and 42%. Overall, 92% of the patients were on statins: 67% were on statin monotherapy, while 33% were on combinations with ezetimibe (25%), -3 fatty acids (5%), fibrates (4%), or colesevelam (2%). Even in a specialist lipid clinic, a large proportion of patients are not at goal according to the recent ESC/EAS guidelines.

引用

页码：346 / 353

页数：8

共 48 条

[1]

Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol [J].

Alsheikh-Ali, Alawi A. ;

Lin, Jen-Liang ;

Abourjaily, Paul ;

Ahearn, Dineli ;

Kuvin, Jeffrey T. ;

Karas, Richard H. .

AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (10) :1499-1501

[2]

Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort [J].

Athyros, Vasilios G. ;

Liberopoulos, Evangelos N. ;

Mikhailidis, Dimitri P. ;

Papageorgiou, Athanasios A. ;

Ganotakis, Emmanuel S. ;

Tziomalos, Konstantinos ;

Kakafika, Anna I. ;

Karagiannis, Asterios ;

Lambropoulos, Stylianos ;

Elisaf, Moses .

ANGIOLOGY, 2007, 58 (06) :689-697

[3]

Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome - A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study [J].

Athyros, Vasilios G. ;

Mikhailidis, Dimitri P. ;

Liberopoulos, Evangelos N. ;

Kakafika, Anna I. ;

Karagiannis, Asterios ;

Papageorgiou, Athanasios A. ;

Tziomalos, Konstantinos ;

Ganotakis, Emmanuel S. ;

Elisaf, Moses .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (01) :118-127

[4]

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis [J].

Athyros, Vasilios G. ;

Tziomalos, Konstantinos ;

Gossios, Thomas D. ;

Griva, Theodora ;

Anagnostis, Panagiotis ;

Kargiotis, Konstantinos ;

Pagourelias, Efstathios D. ;

Theocharidou, Eleni ;

Karagiannis, Asterios ;

Mikhailidis, Dimitri P. .

LANCET, 2010, 376 (9756) :1916-1922

[5]

Long-Term Impact of Multifactorial Treatment on New-Onset Diabetes and Related Cardiovascular Events in Metabolic Syndrome: A Post Hoc ATTEMPT Analysis [J].

Athyros, Vassilios G. ;

Elisaf, Moses S. ;

Alexandrides, Theodore ;

Achimastos, Apostolos ;

Ganotakis, Emmanouel ;

Bilianou, Eleni ;

Karagiannis, Asterios ;

Liberopoulos, Evangelos N. ;

Tziomalos, Konstantinos ;

Mikhailidis, Dimitri P. .

ANGIOLOGY, 2012, 63 (05) :358-366

[6]

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study [J].

Athyros, VG ;

Mikhailidis, DP ;

Papageorgiou, AA ;

Symeonidis, AN ;

Pehlivanidis, AN ;

Bouloukos, VI ;

Elisaf, M .

JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (07) :728-734

[7]

Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates [J].

Baessler, A ;

Fischer, M ;

Huf, V ;

Mell, S ;

Hengstenberg, C ;

Mayer, B ;

Holmer, S ;

Riegger, G ;

Schunkert, H .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 101 (02) :293-298

[8]

Barkas F, 2013, HELLENIC J ATHEROSCL, V4, P31

[9]

Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registry [J].

Bestehorn, Kurt ;

Jannowitz, Christina ;

Karmann, Barbara ;

Pittrow, David ;

Kirch, Wilhelm .

BMC PUBLIC HEALTH, 2009, 9

[10]

Is diabetes a coronary risk equivalent? Systematic review and meta-analysis [J].

Bulugahapitiya, U. ;

Siyambalapitiya, S. ;

Sithole, J. ;

Idris, I. .

DIABETIC MEDICINE, 2009, 26 (02) :142-148

← 1 2 3 4 5 →